Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 291

    1.

    A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease.

    Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, Tjora S, Domanski MJ, Gersh BJ, Rouleau JL, Pfeffer MA, Braunwald E; the Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators.

    N Engl J Med. 2009 Nov 25. [Epub ahead of print]PMID: 19940289 [PubMed - as supplied by publisher]

    2.

    CSCI/RCPSC HENRY FRIESEN LECTURE: Clinical research in Canada: the dawn of a new era?

    Rouleau JL.

    Clin Invest Med. 2009 Oct 1;32(5):E395-404.PMID: 19796581 [PubMed - in process]Related articles

    3.

    The phenotype and potential origin of nestin+ cardiac myocyte-like cells following infarction.

    Béguin PC, El-Helou V, Assimakopoulos J, Clément R, Gosselin H, Brugada R, Villeneuve L, Rohlicek CV, Del Duca D, Lapointe N, Rouleau JL, Calderone A.

    J Appl Physiol. 2009 Oct;107(4):1241-8. Epub 2009 Aug 13.PMID: 19679743 [PubMed - in process]Related articles

    4.

    Coronary bypass surgery with or without surgical ventricular reconstruction.

    Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL; STICH Hypothesis 2 Investigators.

    N Engl J Med. 2009 Apr 23;360(17):1705-17. Epub 2009 Mar 29.PMID: 19329820 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker.

    White M, Rouleau JL, Afzal R, Floras J, Yusuf S, McKelvie RS.

    Ther Adv Cardiovasc Dis. 2009 Apr;3(2):113-21.PMID: 19299427 [PubMed - indexed for MEDLINE]Related articles

    6.

    Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).

    Hernandez AF, O'Connor CM, Starling RC, Reist CJ, Armstrong PW, Dickstein K, Lorenz TJ, Gibler WB, Hasselblad V, Komajda M, Massie B, McMurray JJ, Nieminen M, Rouleau JL, Swedberg K, Califf RM.

    Am Heart J. 2009 Feb;157(2):271-7. Epub 2008 Dec 19.PMID: 19185633 [PubMed - indexed for MEDLINE]Related articles

    7.

    Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).

    Piccini JP, Hranitzky PM, Kilaru R, Rouleau JL, White HD, Aylward PE, Van de Werf F, Solomon SD, Califf RM, Velazquez EJ.

    Am J Cardiol. 2008 Dec 1;102(11):1427-32. Epub 2008 Sep 11.PMID: 19026290 [PubMed - indexed for MEDLINE]Related articles

    8.

    A Canadian context for the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF) trial.

    Armstrong PW, Rouleau JL.

    Can J Cardiol. 2008 Jul;24 Suppl B:30B-2B.PMID: 18629387 [PubMed - indexed for MEDLINE]Related articles

    9.

    Rhythm control versus rate control for atrial fibrillation and heart failure.

    Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O'Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL; Atrial Fibrillation and Congestive Heart Failure Investigators.

    N Engl J Med. 2008 Jun 19;358(25):2667-77.PMID: 18565859 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A forme fruste of Shone's anomaly in a 65 year-old patient.

    Moustafa SE, Lesperance J, Rouleau JL, Gosselin G.

    Mcgill J Med. 2008 Jan;11(1):19-21.PMID: 18523519 [PubMed - in process]Related articlesFree article

    11.

    High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.

    Anderson RE, Pfeffer MA, Thune JJ, McMurray JJ, Califf RM, Velazquez E, White HD, Rouleau JL, Skali H, Maggioni A, Solomon SD.

    Am Heart J. 2008 Apr;155(4):706-11. Epub 2008 Jan 31.PMID: 18371480 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus.

    Anavekar NS, Solomon SD, McMurray JJ, Maggioni A, Rouleau JL, Califf R, White H, Kober L, Velazquez E, Pfeffer MA.

    Am J Cardiol. 2008 Apr 1;101(7):925-9.PMID: 18359309 [PubMed - indexed for MEDLINE]Related articles

    13.

    Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic function.

    Hsia J, Jablonski KA, Rice MM, Sabatine MS, Zabalgoitia M, Maggioni A, Cuddy TE, Domanski MJ, Geller NL, Flaker G, Solomon S, Omland T, Rouleau JL; PEACE Investigators.

    Am J Cardiol. 2008 Feb 15;101(4):457-61.PMID: 18312757 [PubMed - indexed for MEDLINE]Related articles

    14.

    Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.

    Lewis EF, Velazquez EJ, Solomon SD, Hellkamp AS, McMurray JJ, Mathias J, Rouleau JL, Maggioni AP, Swedberg K, Kober L, White H, Dalby AJ, Francis GS, Zannad F, Califf RM, Pfeffer MA.

    Eur Heart J. 2008 Mar;29(6):748-56. Epub 2008 Feb 28.PMID: 18308687 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study.

    Chocron S, Baillot R, Rouleau JL, Warnica WJ, Block P, Johnstone D, Myers MG, Calciu CD, Nozza A, Martineau P, van Gilst WH; IMAGINE Investigators.

    Eur Heart J. 2008 Mar;29(5):673-9. Epub 2008 Feb 19.PMID: 18285358 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial.

    Torre-Amione G, Anker SD, Bourge RC, Colucci WS, Greenberg BH, Hildebrandt P, Keren A, Motro M, Moyé LA, Otterstad JE, Pratt CM, Ponikowski P, Rouleau JL, Sestier F, Winkelmann BR, Young JB; Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy Investigators.

    Lancet. 2008 Jan 19;371(9608):228-36.PMID: 18207018 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.

    Rouleau JL, Warnica WJ, Baillot R, Block PJ, Chocron S, Johnstone D, Myers MG, Calciu CD, Dalle-Ave S, Martineau P, Mormont C, van Gilst WH; IMAGINE (Ischemia Management with Accupril post-bypass Graft via Inhibition of the coNverting Enzyme) Investigators.

    Circulation. 2008 Jan 1;117(1):24-31. Epub 2007 Dec 10.PMID: 18071079 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.

    Thune JJ, Signorovitch J, Kober L, Velazquez EJ, McMurray JJ, Califf RM, Maggioni AP, Rouleau JL, Howlett J, Zelenkofske S, Pfeffer MA, Solomon SD.

    Hypertension. 2008 Jan;51(1):48-54. Epub 2007 Nov 19.PMID: 18025296 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial.

    Velazquez EJ, Lee KL, O'Connor CM, Oh JK, Bonow RO, Pohost GM, Feldman AM, Mark DB, Panza JA, Sopko G, Rouleau JL, Jones RH; STICH Investigators.

    J Thorac Cardiovasc Surg. 2007 Dec;134(6):1540-7.PMID: 18023680 [PubMed - indexed for MEDLINE]Related articles

    20.

    Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an acute myocardial infarction.

    Mielniczuk LM, Lamas GA, Flaker GC, Mitchell G, Smith SC, Gersh BJ, Solomon SD, Moyé LA, Rouleau JL, Rutherford JD, Pfeffer MA.

    Congest Heart Fail. 2007 Jul-Aug;13(4):209-14.PMID: 17673873 [PubMed - indexed for MEDLINE]Related articles

    21.

    Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

    Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E; PEACE Investigators.

    J Am Coll Cardiol. 2007 Jul 17;50(3):205-14. Epub 2007 Jun 29.PMID: 17631211 [PubMed - indexed for MEDLINE]Related articles

    22.

    Lack of long-term benefits of a 6-month heart failure disease management program.

    Nguyen V, Ducharme A, White M, Racine N, O'Meara E, Zhang B, Rouleau JL, Brophy J.

    J Card Fail. 2007 May;13(4):287-93.PMID: 17517349 [PubMed - indexed for MEDLINE]Related articles

    23.

    A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design.

    Torre-Amione G, Bourge RC, Colucci WS, Greenberg B, Pratt C, Rouleau JL, Sestier F, Moyé LA, Geddes JA, Nemet AJ, Young JB; ACCLAIM Investigators.

    Can J Cardiol. 2007 Apr;23(5):369-76.PMID: 17440642 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Effects of combined candesartan and ACE inhibitors on BNP, markers of inflammation and oxidative stress, and glucose regulation in patients with symptomatic heart failure.

    White M, Lepage S, Lavoie J, De Denus S, Leblanc MH, Gossard D, Whittom L, Racine N, Ducharme A, Dabouz F, Rouleau JL, Touyz R.

    J Card Fail. 2007 Mar;13(2):86-94.PMID: 17395047 [PubMed - indexed for MEDLINE]Related articles

    25.

    Navigating the crossroads of coronary artery disease and heart failure.

    Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PF, Sadowski Z, Golba KS, Prior DL, Rouleau JL, Bonow RO.

    Circulation. 2006 Sep 12;114(11):1202-13. Review. No abstract available. PMID: 16966596 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    The heart failure challenge: optimizing medical and surgical management.

    Racine N, Rouleau JL.

    Can J Cardiol. 2006 Aug;22 Suppl C:8C-12C. Review.PMID: 16929385 [PubMed - indexed for MEDLINE]Related articles

    27.

    Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction.

    Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, Moye L, Pfeffer MA, Solomon SD.

    J Am Soc Nephrol. 2006 Oct;17(10):2886-91. Epub 2006 Aug 23.PMID: 16928807 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.

    Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJ, Olsson L, Rouleau JL, Young JB, Olofsson B, Puu M, Yusuf S; CHARM Investigators.

    Am Heart J. 2006 Jul;152(1):86-92.PMID: 16838426 [PubMed - indexed for MEDLINE]Related articles

    29.
    30.

    Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program.

    Ducharme A, Swedberg K, Pfeffer MA, Cohen-Solal A, Granger CB, Maggioni AP, Michelson EL, McMurray JJ, Olsson L, Rouleau JL, Young JB, Yusuf S.

    Am Heart J. 2006 May;151(5):985-91. Erratum in: Am Heart J. 2006 Aug;152(2):354. PMID: 16644318 [PubMed - indexed for MEDLINE]Related articles

    31.

    Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction.

    Køber L, Swedberg K, McMurray JJ, Pfeffer MA, Velazquez EJ, Diaz R, Maggioni AP, Mareev V, Opolski G, Van de Werf F, Zannad F, Ertl G, Solomon SD, Zelenkofske S, Rouleau JL, Leimberger JD, Califf RM.

    Eur J Heart Fail. 2006 Oct;8(6):591-8. Epub 2006 Feb 28.PMID: 16507350 [PubMed - indexed for MEDLINE]Related articles

    32.

    Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.

    White M, Ducharme A, Ibrahim R, Whittom L, Lavoie J, Guertin MC, Racine N, He Y, Yao G, Rouleau JL, Schiffrin EL, Touyz RM.

    Clin Sci (Lond). 2006 Apr;110(4):483-9.PMID: 16402915 [PubMed - indexed for MEDLINE]Related articles

    33.

    Losartan and acute myocardial infarction in insulin-resistant Zucker fatty rats: reduced ventricular arrhythmias and improved survival.

    Pourdjabbar A, Parker TG, Desjardins JF, Nguyen QT, Tsoporis JN, Lapointe N, Rouleau JL.

    Can J Physiol Pharmacol. 2005 Nov;83(11):989-98.PMID: 16391707 [PubMed - indexed for MEDLINE]Related articles

    34.

    Vasopeptidase inhibition peri- and post-MI in Zucker insulin resistant rats: effect on MI size, arrhythmias, remodeling, function and fetal gene expression.

    Lapointe N, Nguyen QT, Desjardins JF, Tsoporis J, Marcotte F, Pourdjabbar A, Parker TG, Moe G, Adam A, Rouleau JL.

    Cardiovasc Drugs Ther. 2005 Oct;19(5):323-32.PMID: 16382294 [PubMed - indexed for MEDLINE]Related articles

    35.

    The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry.

    Kauf TL, Velazquez EJ, Crosslin DR, Weaver WD, Diaz R, Granger CB, McMurray JJ, Rouleau JL, Aylward PE, White HD, Califf RM, Schulman KA.

    Am Heart J. 2006 Jan;151(1):206-12.PMID: 16368320 [PubMed - indexed for MEDLINE]Related articles

    36.

    Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study.

    Krum H, Mohacsi P, Katus HA, Tendera M, Rouleau JL, Fowler MB, Coats AJ, Roecker EB, Packer M; Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group.

    Am Heart J. 2006 Jan;151(1):55-61.PMID: 16368292 [PubMed - indexed for MEDLINE]Related articles

    37.

    Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial).

    Dupuis J, Tardif JC, Rouleau JL, Ricci J, Arnold M, Lonn E, Roux R, Title LM, Amyot R, Bonafede N, Woo A, Cannon CP.

    Am J Cardiol. 2005 Nov 1;96(9):1207-13. Epub 2005 Sep 6.PMID: 16253583 [PubMed - indexed for MEDLINE]Related articles

    38.

    Treatment of congestive heart failure: present and future.

    Rouleau JL.

    Can J Cardiol. 2005 Oct;21(12):1084-8.PMID: 16234894 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Left ventricular assessment in myocardial infarction: the VALIANT registry.

    Hernandez AF, Velazquez EJ, Solomon SD, Kilaru R, Diaz R, O'Connor CM, Ertl G, Maggioni AP, Rouleau JL, van Gilst W, Pfeffer MA, Califf RM; VALIANT Registry.

    Arch Intern Med. 2005 Oct 10;165(18):2162-9.PMID: 16217008 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Prognostic use of echocardiography 1 year after a myocardial infarction.

    Skali H, Zornoff LA, Pfeffer MA, Arnold MO, Lamas GA, Moyé LA, Plappert T, Rouleau JL, Sussex BA, St John Sutton M, Braunwald E, Solomon SD; Survival and Ventricular Enlargement (SAVE) Investigators.

    Am Heart J. 2005 Oct;150(4):743-9.PMID: 16209977 [PubMed - indexed for MEDLINE]Related articles

    41.

    A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors.

    Duan QL, Nikpoor B, Dube MP, Molinaro G, Meijer IA, Dion P, Rochefort D, Saint-Onge J, Flury L, Brown NJ, Gainer JV, Rouleau JL, Agostoni A, Cugno M, Simon P, Clavel P, Potier J, Wehbe B, Benarbia S, Marc-Aurele J, Chanard J, Foroud T, Adam A, Rouleau GA.

    Am J Hum Genet. 2005 Oct;77(4):617-26. Epub 2005 Sep 1.PMID: 16175507 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.

    Yan RT, White M, Yan AT, Yusuf S, Rouleau JL, Maggioni AP, Hall C, Latini R, Afzal R, Floras J, Masson S, McKelvie RS; Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Investigators.

    Am J Cardiol. 2005 Sep 1;96(5):698-704.PMID: 16125499 [PubMed - indexed for MEDLINE]Related articles

    43.

    Do statins prevent heart failure in patients after myocardial infarction?

    Ducharme A, Rouleau JL.

    Curr Heart Fail Rep. 2004 Dec;1(4):156-60. Review.PMID: 16036039 [PubMed - indexed for MEDLINE]Related articles

    44.

    Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial.

    Ducharme A, Doyon O, White M, Rouleau JL, Brophy JM.

    CMAJ. 2005 Jul 5;173(1):40-5.PMID: 15997043 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.

    Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA; Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators.

    N Engl J Med. 2005 Jun 23;352(25):2581-8. Erratum in: N Engl J Med. 2005 Aug 18;353(7):744. PMID: 15972864 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry.

    Szummer KE, Solomon SD, Velazquez EJ, Kilaru R, McMurray J, Rouleau JL, Mahaffey KW, Maggioni AP, Califf RM, Pfeffer MA, White HD; VALIANT Registry.

    Eur Heart J. 2005 Oct;26(20):2114-9. Epub 2005 Jun 21.PMID: 15972293 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial.

    Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, Esmatjes E, Hricik D, Pohl M, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber SZ, Lewis EJ; Collaborative Study Group.

    J Am Soc Nephrol. 2005 Jul;16(7):2170-9. Epub 2005 Jun 1.PMID: 15930097 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.

    Stanton E, Hansen M, Wijeysundera HC, Kupchak P, Hall C, Rouleau JL; PRAISE-2 study investigators.

    Eur J Heart Fail. 2005 Jun;7(4):557-65.PMID: 15921795 [PubMed - indexed for MEDLINE]Related articles

    49.

    Effects of the vasopeptidase inhibitor omapatrilat on peri- and postmyocardial infarction in Zucker lean rats.

    Lapointe N, Parker TG, Tsoporis JN, Nguyen QT, Marcotte F, Adam A, Lou I, Rouleau JL.

    Can J Cardiol. 2005 Mar;21(3):291-7.PMID: 15776120 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure.

    Stanton EB, Hansen MS, Sole MJ, Gawad Y, Packer M, Pitt B, Swedberg K, Rouleau JL; PROFILE investigators.

    Can J Cardiol. 2005 Jan;21(1):39-43.PMID: 15685301 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...